Table 2.
The 15 lipids with the largest and most significant differences between patients and controls
| Lipid name | Fold (IBS/healthy control) | P value1 | FDR Q value |
| Cer (d18:1/24:1) | 1.3 | 0.001 | 0.022 |
| Cer (d18:1/24:2) | 1.4 | 0.00004 | 0.0018 |
| DG (36:2) | 1.9 | 0.000001 | 0.0003 |
| GlycoSL (m/z = 1199.805) | 1.9 | 0.001 | 0.018 |
| GlycoSL (m/z = 1195.851) | 2.0 | 0.0003 | 0.0069 |
| lysoPC (16:0) | 2.1 | 0.00006 | 0.0020 |
| lysoPC (18:0) | 1.9 | 0.0002 | 0.0049 |
| lysoPC (18:1) | 2.8 | 0.00002 | 0.0013 |
| lysoPE (18:1e) | 2.4 | 0.00002 | 0.0013 |
| 7TG (46:5) | 1.4 | 0.04 | 0.19 |
| TG (48:5) | 1.6 | 0.03 | 0.17 |
| TG (48:6) | 1.7 | 0.03 | 0.18 |
| TG (49:3) | 2.1 | 0.009 | 0.089 |
| TG (51:4) | 1.6 | 0.04 | 0.19 |
| TG (51:5) | 1.8 | 0.02 | 0.12 |
1
Wilcoxon rank sum test. Cer: Ceramide; DG: Diacylglycerol; GlycoSL: Glycosphingolipid; lysoPC: Lysophosphatidylcholine; lysoPE: Lysophosphatidylethanolamine; TG: Triacylglycerol.